Enanta Pharmaceuticals, Inc.
Extract: Discloses AGM Date from a 10-K on 11/23/2022   Download
SEC Document
SEC Filing

Portions of the registrant’s Definitive Proxy Statement for its 2023 Annual Meeting of Stockholders scheduled to be held on March 2, 2023, which Definitive Proxy will be filed with the Securities and Exchange Commission not later than 120 days after the registrant’s fiscal year end of September 30, 2022 are incorporated by reference into Part III of this Form 10-K.